OncoVerity

OncoVerity, based in Denver, CO, the United States, is a biotechnology company. OncoVerity applies computational tools to clinical and biologic data to develop personalised cancer therapies. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing Cusatuzumab in acute myeloid leukaemia. The largest, NCT06384261 (A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy), plans to enrol 140 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.